FDA rejects drug for rare blood disorder
 The US Food and Drug Administration has rejected a small molecule for a rare blood disorder called…
Consumer group presses U.S. to authorize generic GLP-1s
Public Citizen petitioned the Trump administration to use a federal law to authorize generic competitors for GLP-1 drugs…
CRISPR Unlocks a New Path to Stronger Medicinal Plants
Newswise — Medicinal plants synthesize a wide range of specialized metabolites that form the foundation of many modern…
Crick spin‑out ALTx will target cancer cell immortality
 Founded in late 2024, ALTx Therapeutics has come out of stealth mode with plans to develop therapies…
Hims is in the crosshairs. What does it mean for compounding?
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
Novo Nordisk sues Hims & Hers over compounded obesity drugs
Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper,…
Taking the new Wegovy pill every day is really complicated. Will patients stick with it?
Published: Feb. 10, 2026 at 3:48 p.m. ET Patients are thrilled that there’s finally a GLP-1 pill, but swallowing…
CVS Health (CVS) earnings Q4 2025
A pedestrian walks by a CVS store in Greenbrae, California, on July 31, 2025. Justin Sullivan | Getty…
Hims & Hers compounder received FDA warning letter| STAT
The Food and Drug Administration late last year issued a warning letter to MedisourceRx, a compounding pharmacy owned…
Painkillers and HRT therapies among drugs not being subsidised under PBS
Patients are being hit with excessive costs on a range of everyday prescription medicines because of flaws in…
Do statins really cause those side effects? What the data shows
Far fewer people who could benefit from statins actually take the cholesterol-lowering drugs now. Many who start taking…
Hims & Hers falls 8% after Novo’s legal threat. Here’s the latest
Rafael Henrique | SOPA Images | AP The stock of Hims & Hers dropped in premarket trading early…